Free tools Windows power users keep installed
One-click scans. No signup required.
Choose an electronic quality management system (eQMS) by mapping the quality processes and records your startup must control, then testing candidate systems against those workflows. Prioritize usable evidence, proportionate software assurance, manageable administration, and a path to scale—not a vendor’s claim that its platform makes you compliant.
Start with the regulatory context, not a vendor shortlist
For US medical-device manufacturers within its scope, FDA’s Quality Management System Regulation (QMSR) took effect on February 2, 2026. It amends 21 CFR Part 820 and incorporates ISO 13485:2016 by reference. The requirements that apply to a company depend on its device and regulatory context; the effective date does not mean every startup has identical obligations.
FDA’s February 2026 final guidance, Computer Software Assurance for Production and Quality Management System Software, addresses software used in production or a quality management system. Its risk-based approach is relevant to an eQMS: the company should determine and document assurance activities appropriate to how it uses the system and the risks involved. The guidance does not certify eQMS products or endorse a particular vendor.
SaMD adds lifecycle considerations. FDA describes the IMDRF SaMD quality-system framework as a shared vocabulary for applying QMS requirements to software as a medical device. IMDRF principles are not regulations by themselves; jurisdictions adopt them through their own regulatory frameworks.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →#1 Best Overall
Map the quality work your team actually needs to control
Before requesting demos, write down the processes you need to run, the records each process produces, who owns them, and how you will retrieve them. Use your quality-system procedures and applicable market requirements as the source of truth; a feature list alone does not establish that a workflow is adequate.
Cover the SaMD lifecycle
Check whether your planned workflows address the lifecycle activities relevant to your product and QMS:
Rank #2
- Ideal for Gifting
- Ideal for a bookworm
- Compact for travelling
- Requirements management
- Design and development
- Verification and validation
- Deployment
- Maintenance
- Decommissioning
These are lifecycle areas identified in IMDRF’s SaMD QMS principles. The processes should scale with organizational size and be applied consistently. A small team may have fewer handoffs than a large manufacturer, but it still needs to define how the work and its records are controlled.
Translate each process into records and responsibilities
For each workflow, specify what starts it, who reviews or approves it, what record is retained, how a change is handled, and how someone will find the record later. Include the people who will administer the system and maintain the process—not only the person selecting software. This exposes gaps such as an unassigned review step or a record that cannot be readily retrieved.
Compare systems against the same evidence-based criteria
Use a consistent set of scenarios for every candidate. Ask the vendor to demonstrate your intended workflows and show the records those workflows produce. The comparison below is a buyer’s evaluation framework, not an FDA scoring model.
| Evaluation area | What to establish | Demo or diligence prompt |
|---|---|---|
| Lifecycle workflow coverage | Whether the system can support the processes your QMS actually uses across relevant SaMD lifecycle work. | “Show how our team would create, review, approve, change, and retrieve a record for this workflow.” |
| Software assurance evidence | What evidence you can retain about intended use, risk, configuration, testing, access, changes, and ongoing use. | “What documentation and system records can we review to support our own risk-based assurance activities?” |
| Team and process fit | Whether the setup and day-to-day work are manageable for the people who will own configuration, training, records, and process maintenance. | “Which tasks require an administrator, and what would our process owner do in a typical review?” |
| Regulatory mapping | How your workflows and records map to applicable obligations in the US and any other target markets. | “Show the records and workflow controls we would use; explain what the system does not provide.” |
| Retrieval and operational burden | How quickly and reliably the team can create, approve, locate, and maintain required records. | “Find this approved record, show its history, and demonstrate how a permitted change is handled.” |
| Scale and change | Whether the system can accommodate expected changes in products, markets, users, and processes. | “How would we add a workflow or user group, and what changes would require new configuration or training?” |
| Implementation and total cost | Current quoted costs and the effort for migration, configuration, training, administration, and growth. | “Provide a current quote and identify implementation work, ongoing fees, and responsibilities on both sides.” |
Ask vendors for supporting documentation and verify answers rather than relying on demo promises. For a comparison between two or more systems, use identical scenarios and assess the resulting evidence, implementation effort, support, security documentation, data export, and current total cost. Pricing and product capabilities are vendor-specific and can change; request current terms rather than relying on an assumed market range.
Rank #4
Assess the eQMS itself as software used in a QMS
An eQMS is not outside the quality system merely because it is the tool used to run it. Define its intended use within your processes and determine what assurance is proportionate to that use and risk, following FDA’s February 2026 computer software assurance guidance where applicable. Keep the rationale and evidence that support your decision.
During selection, ask what the vendor can document about configuration, testing, access, and changes, and what your team must assess or perform. Distinguish vendor-provided material from your company’s own assurance decisions: buying a system or receiving vendor documentation does not, by itself, establish that your use is adequately controlled.
Do these 3 things before closing this tab:
1Clear out junk files and repair common Windows errors2Fix the driver behind crashes, sound loss and screen glitches3Repair Windows errors before they cause bigger problemsBest Value
- It can be a gift option
- Comes with secure packaging
- Helpful in various ways
Calculate the operating commitment, not just the quoted price
There is no established comparable eQMS price in the cited regulatory sources. Get current quotes from vendors and evaluate the full commitment, including setup, migration, configuration, training, ongoing administration, support, and the cost of expected growth. Also identify how much internal time the system will require and who will own that work. A lower initial quote may not mean a lower overall burden if substantial configuration or maintenance falls to a small team.
Use a structured selection process
- Define scope. Identify the device, intended markets, applicable quality-system context, and processes that need control. For US market entry, FDA describes a product-specific path involving device classification and applicable controls, the appropriate premarket submission where required, submission to FDA, and relevant regulatory controls such as establishment registration and device listing.
- Map workflows and records. For each relevant lifecycle process, document the responsible roles, approvals, resulting records, change handling, and retrieval needs.
- Set your must-haves. Separate essential workflow and evidence needs from preferences. Include team capacity, implementation work, support, security documentation, data export, and expected growth.
- Run comparable demonstrations. Give each candidate the same realistic scenarios and ask to see the resulting records and how they can be reviewed and retrieved.
- Review assurance and implementation evidence. Establish what the vendor supplies, what your organization must assess, the configuration and migration effort, and how changes will be handled.
- Compare current total cost and ownership. Use current quotes and name the internal owners for system administration, training, and process maintenance before selecting a platform.
- Document the decision. Record why the chosen system fits the intended workflows, what gaps remain, and what your team will do to address them. Keep the rationale proportionate to the decision and your use of the software.
Keep product pathway decisions connected to QMS planning
FDA defines SaMD as “software intended to be used for one or more medical purposes that perform these purposes without being part of a hardware medical device,” attributing that definition to IMDRF. Whether a product meets the definition and what US pathway applies are product-specific questions. The intended market and classification affect which regulatory controls and submission steps are relevant, so resolve those questions alongside—not after—quality-process planning.
FDA’s page for Quality Management System Information for Certain Premarket Submission Reviews describes an October 2025 draft guidance. FDA labels it “Not for implementation. Contains non-binding recommendations.” Treat it as draft material, not as a final requirement or a substitute for the current requirements applicable to your product.
Quick Recap
Warning signs during evaluation
- The sales presentation treats a platform purchase, template set, or vendor label as proof of compliance.
- A vendor cannot demonstrate your workflows with the records and review steps your team needs to evaluate.
- The team has not assigned ownership for configuration, training, access, or ongoing process maintenance.
- The business case relies on an unverified feature, security, certification, implementation, or pricing claim.
- The proposed system’s workflows are being mistaken for a decision about device classification or the right premarket pathway.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
